Cancer In Context

This book offers healthcare professionals, academics and anyone affected by cancer a fresh and original approach to the supportive care of people with cancer. It looks at some of the underlying reasons why cancer often leads to high levels of distress. More importantly, it suggests many practical ways distress can be prevented and minimised. The book combines the actual experiences of cancer patients, as recorded in their personal diaries, with theory, research and practical clinical advice. In each of its seven chapters the book takes a different perspective and a different approach to supportive care in cancer. Chapter 1 considers how people generally manage and adjust to change in their lives and in particular how they react to the threat of cancer. Chapter 2 examines the 'lived experience' of people with cancer as they negotiate the many challenges and changes following their diagnosis. Chapter 3 looks at the impact of cancer on the families, partners, and carers of people with cancer. Chapter 4 shows that the social and cultural context of someone's life is critical to an understanding of their resources and responses to serious illness. Chapter 5 considers how professionals can help minimise disruption to their patients quality of life as they endure the notorious demands of oncology treatments. It looks at popular cancer treatments, common treatment difficulties, cancer rehabilitation and palliative care. Chapter 6 provides a summary of the burgeoning area of communication skills within healthcare and, finally, Chapter 7 ponders how professionals can maintain adequate supportive care in light of the evidence of high levels of stress and burnout among cancer staff.

Healthcare professionals, academics and anyone affected by cancer will find here a fresh approach to the supportive care of people with cancer. The author looks at why cancer can lead to high levels of distress and suggests practical ways in which distress can be prevented and minimized.

The needs of cancer patients and their families are complex. Yetstill more complex are the powerful social and cultural forces thatshape the delivery of cancer care, and the way in which itexperienced. Cancer Nursing: Care in Context addresses this byadopting a unique approach that situates cancer care in the contextof society's attitudes to the disease, and the broader every-dayneeds of both patients and their carers. By combiningevidenced-based information, a critical view of care and treatment,and 'first-hand accounts' of having cancer and caring for peoplewith cancer, the book provides a new perspective how best todeliver the care that patients truly require. This second edition includes new chapters on prevention, diagnosis,symptoms, self-help and self-management, and living with cancerlong-term. It also: * Addresses significant changes in cancer care, including expansionof nursing roles, the establishment of cancer networks and cancercollaborative projects * Considers NICE guidance on Supportive and Palliative care * Incorporates material on prevention and early detection * Includes evidence tables based on relevant literature Cancer Nursing: Care in Context is an invaluable resource for allthose involved in the provision of cancer care and support topatients and their families.

This comprehensive text provides a detailed overview of the molecular mechanisms underpinning the development of cancer and its treatment. Written by an international panel of researchers, specialists and practitioners in the field, the text discusses all aspects of cancer biology from the causes, development and diagnosis through to the treatment of cancer. Written by an international panel of researchers, specialists and practitioners in the field Covers both traditional areas of study and areas of controversy and emerging importance, highlighting future directions for research Features up-to-date coverage of recent studies and discoveries, as well as a solid grounding in the key concepts in the field Each chapter includes key points, chapter summaries, text boxes, and topical references for added comprehension and review Supported by a dedicated website at www.blackwellpublishing.com/pelengaris An excellent text for upper-level courses in the biology of cancer, for medical students and qualified practitioners preparing for higher exams, and for researchers and teachers in the field

"This book focusing on the immunopathology of cancers is published as part of the three-volume Springer series Cancer Immunology, which aims to provide an up-to-date, clinically relevant review of cancer immunology and immunotherapy. Readers will find detailed descriptions of the interactions between cancerous cells and various components of the innate and adaptive immune system. The principal focus, however, is very much on clinical aspects, the aim being to educate clinicians in the clinical implications of the latest research and novel developments in the field. In the new edition of this very well received book, first published in 2015, the original chapters have been significantly updated and additional chapters included on, for example, current knowledge on the roles of T-helper cells and NK cells in tumor immunity, the part played by oncoviruses in the development of various cancers, and the applications of fluorescent in situ hybridization, bioluminescence, and cancer molecular and functional imaging"--Publisher's description.

Cancer Genomics addresses how recent technological advances in genomics are shaping how we diagnose and treat cancer. Built on the historical context of cancer genetics over the past 30 years, the book provides a snapshot of the current issues and state-of-the-art technologies used in cancer genomics. Subsequent chapters highlight how these approaches have informed our understanding of hereditary cancer syndromes and the diagnosis, treatment and outcome in a variety of adult and pediatric solid tumors and hematologic malignancies. The dramatic increase in cancer genomics research and ever-increasing availability of genomic testing are not without significant ethical issues, which are addressed in the context of the return of research results and the legal considerations underlying the commercialization of genomic discoveries. Finally, the book concludes with "Future Directions", examining the next great challenges to face the field of cancer genomics, namely the contribution of non-coding RNAs to disease pathogenesis and the interaction of the human genome with the environment. Tools such as sidebars, key concept summaries, a glossary, and acronym and abbreviation definitions make this book highly accessible to researchers from several fields associated with cancer genomics. Contributions from thought leaders provide valuable historical perspective to relate the advances in the field to current technologies and literature.

This book describes the molecular mechanisms of lung cancer development and progression that determine therapeutic interventions in the era of genomics, when the rapid evolution in lung cancer diagnosis and treatment necessitates critical review of new results to integrate advances into practice. The text opens with background and emerging information regarding the molecular biology of lung cancer pathogenesis. Updated results regarding lung cancer prevention and screening are discussed, followed by chapters on diagnostic techniques and pathological evaluation. This leads on to a detailed presentation of treatment modalities, from surgery and radiation therapy to standard chemotherapy and targeted agents. The coverage includes resistance to therapy and the emergence of immunotherapy for lung cancer; in addition, the current evidence in respect of small cell lung cancer is summarized. The book presents insights from experts across disciplines to emphasize the importance of collaborative care. Advances in our understanding of issues in geriatric oncology and palliative care complete the comprehensive discussion of lung cancer.

Bioengineering Innovative Solutions for Cancer bridges the gap between bioengineering and cancer biology. It focuses on a 'bottom up' understanding of the links between molecules, cells, tissues, organs, organisms, and health and functions-all within a bioengineering context. Chapters cover the main methods, technologies and devices that could help diagnose cancer sooner (e.g., ultrasensitive imaging and sensing technologies) and helpful treatments (e.g., new, more targeted therapies). The book takes an interdisciplinary approach that is ideal for those who need the latest information on design techniques and devices that help treat cancer using new, more targeted therapies. By covering the many different ways engineers can deliver innovative solutions to tackle cancer, this book is a valuable read for researchers who have an ambition to make an impact on people's life in either an academic or industrial setting.